Background-Data regarding the relationships of diabetes, insulin resistance, and subclinical hyperinsulinemia/hyperglycemia with cardiac structure and function are conflicting. We sought to apply volumetric cardiovascular magnetic resonance (CMR) in a free-living cohort to potentially clarify these associations. Methods and Results-A total of 1603 Framingham Heart Study Offspring participants (age, 64Ϯ9 years; 55% women) underwent CMR to determine left ventricular mass (LVM), LVM to end-diastolic volume ratio (LVM/LVEDV), relative wall thickness (RWT), ejection fraction, cardiac output, and left atrial size. Data regarding insulin resistance (homeostasis model, HOMA-IR) and glycemia categories (normal, impaired insulinemia or glycemia, prediabetes, and diabetes) were determined. In a subgroup (253 men, 290 women) that underwent oral glucose tolerance testing, we related 2-hour insulin and glucose with CMR measures. In both men and women, all age-adjusted CMR measures increased across HOMA-IR quartiles, but multivariable-adjusted trends were significant only for LVM/ht 2.7 and LVM/LVEDV. LVM/LVEDV and RWT were higher in participants with prediabetes and diabetes (in both sexes) in age-adjusted models, but these associations remained significant after multivariable adjustment only in men. LVM/LVEDV was significantly associated with 2-hour insulin in men only, and RWT was significantly associated with 2-hour glucose in women only. In multivariable stepwise selection analyses, the inclusion of body mass index led to a loss in statistical significance. Conclusions-Although insulin and glucose indices are associated with abnormalities in cardiac structure, insulin resistance and worsening glycemia are consistently and independently associated with LVM/LVEDV. These data implicate hyperglycemia and insulin resistance in concentric LV remodeling. (Circ Cardiovasc Imaging. 2010;3:257-263.)
D iabetes is an important risk factor for heart failure. [1] [2] [3] One potential mechanism for the predisposition to heart failure in people with diabetes is the direct toxic effect of hyperinsulinemia and hyperglycemia on cardiomyocytes and the surrounding interstitium, leading to maladaptive changes in cardiac structure and function that antedate the development of clinical heart failure. 4 -6 Several investigators have examined the associations of abnormalities in insulin and glucose metabolism (eg, insulin resistance, impaired fasting glucose) in individuals without overt diabetes to indices of cardiac structure and function [7] [8] [9] [10] [11] [12] and heart failure. 13 Many prior studies have been inconsistent, reporting both a positive association 7, 10, 11 and a lack of association. 8, 9, 12 These previ-ous studies have largely used transthoracic echocardiographic measures for cardiac structural measurements. Twodimensional echocardiography is a widely available noninvasive technology. However, echocardiography leads to exclusion of many older subjects and those with higher body mass index (BMI) due to inadequate echocardiograph quality, 10 thereby limiting evaluation of all age groups and the full range of BMI in the population.
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Cardiovascular MRI (CMR) provides a volumetric assessment of cardiac structure and function with successful acquisitions of highly accurate and reproducible datasets, 14 including determination of left ventricular (LV) concentricity, in nearly all subjects. 15, 16 Application of CMR (or other volumetric methods) may therefore facilitate more accurate analysis of the associations of glycemia indices and cardiac measures. We sought to apply CMR methods to further elucidate the potential relationship of increasing insulin resistance, elevated levels of insulin and glucose with cardiac structure, and to determine if the presence of prediabetes and diabetes is associated with alterations of cardiac structure and function compared to the presence of normal insulin and glucose measures.
Methods

Study Sample and Design
The design and characteristics of the Framingham Heart Study Offspring cohort have been described elsewhere. 17 Briefly, members of the Offspring cohort, (comprising the 5124 children of the original cohort and their spouses) were enrolled in 1971 and have been evaluated approximately every 4 years ("examination cycles"). Examination cycle 7, attended by 3799 participants during the years 1998 to 2001, constituted the sampling frame for this study. Among cycle 7 attendees, 1794 participants with normal sinus rhythm and no contraindications to CMR imaging underwent a CMR study between the years 2002 and 2005 and had contemporaneous fasting glucose and insulin levels available. Participants with an incomplete or poor-quality CMR and participants with clinical coronary insufficiency, myocardial infarction, or heart failure, were excluded. The remaining 1603 individuals formed the sample for this study. Participants provided written informed consent for CMR and cycle 7 examinations and testing. The study was approved by the Institutional Review Boards of Boston Medical Center and Beth Israel Deaconess Medical Center.
Assessment of Glucose and Insulin Levels and Insulin Resistance
Baseline samples for glucose and insulin were drawn after an overnight fast. In a stratified subsample, we also obtained measurements 2 hours after a 75-g glucose load administered to fasting participants (2-hour insulin and 2-hour glucose).
Glucose measurements were performed with a hexokinase reagent kit (Roche Diagnostics, Indianapolis, Ind). Insulin measurements were done by radioimmunoassay (Trinity Biotech, St Louis, Mo). The homeostasis model assessment for insulin resistance (HOMA-IR) was calculated as 18 : HOMA-IRϭfasting glucose (mmol/L)ϫfasting insulin (U/mL)/22.5.
Both elevated fasting glucose and fasting insulin predict incident diabetes. 19, 20 Fasting insulin is highly correlated with HOMA-IR, 21 and a threshold of 75th percentile has been previously described as identifying those with insulin resistance and increased risk for cardiovascular disease. [22] [23] [24] Therefore, we used a fasting plasma glucose threshold of 100 mg/dL and a fasting plasma insulin threshold of 75th percentile to classify participants into a spectrum of worsening glycemic milieu as follows: (1) diabetes (nϭ122), including those with a fasting plasma glucose Ն126 mg/dL or receiving insulin or other hypoglycemic therapy; (2) prediabetes (nϭ176), for those without diabetes but with both fasting glucose Ͼ100 mg/dL and fasting insulin Ͼ75th percentile of distribution; (3) impaired insulinemia/glycemia (nϭ442) included those participants with either fasting insulin Ͼ75th percentile of distribution or fasting glucose Ͼ100 mg/dL (but not both); and (4) normal (nϭ863), including those with both fasting glucose Յ100 mg/dL and fasting insulin Յ75th percentile of distribution.
Definition of Covariates
Data for covariates were obtained from the contemporaneous examination cycle. Blood pressure was calculated using the average of 2 auscultated measurements performed while seated. Hypertension was defined as a systolic blood pressure Ͼ140 mm Hg or a diastolic blood pressure Ͼ90 mm Hg or receiving antihypertensive therapy. "Cardioactive drugs" were defined as agents with consistent evidence for favorable effects on LV remodeling, and they include angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, or aldosterone antagonists. 25, 26 Smoking status was defined as regular smoking in the year preceding the examination.
CMR Methods and Definition of Cardiac Measures
Cine CMR images were acquired with subjects in the supine position on a 1.5-T CMR scanner (Gyroscan ACS/NT, Phillips Medical Systems, Best, The Netherlands) using a 5-element cardiac array receiver coil. Eight to 12 contiguous 10-mm-thick LV short-axis images were acquired using an ECG-gated, steady-state free precession sequence, with a 30 to 40 ms temporal resolution and 1.92ϫ1.56 mm 2 in-plane spatial resolution, during a series of end-tidal breath holds.
Epicardial (end-diastolic) and endocardial (end-diastolic and end-systolic) borders were manually traced by a blinded expert observer (C.J.S.) using an EasyScil workstation (Phillips Medical Systems). LV end-diastolic and end-systolic volumes (EDV and ESV) were calculated integrating over multiple slices using the summation of discs method. LV mass (LVM) was calculated by multiplying diastolic LV myocardial volume with density of myocardium (1.05 g/mL), and indexed to height 2.7 . We divided LVM by LVEDV to obtain the LVM/LVEDV ratio (also known as concentricity). LV ejection fraction (EF) was calculated as (EDVϪESV)/EDV. Cardiac output was calculated as (EDVϪESV)ϫheart rate. LV end-diastolic dimension (LVEDD) and inferolateral wall thickness (ILWT) were measured in end-diastole from a short-axis frame immediately basal to the tip of papillary muscle tips. Relative wall thickness (RWT) was calculated as 2ϫILWT/LVEDD. The intraobserver correlations for duplicate readings for LV EDV and ESV were 0.95 and 0.92, respectively.
Statistical Analysis
We compared men and women with regard to categorical clinical variables using the 2 test. For continuous clinical variables and for CMR measures, we compared the sexes using the t test. In our prespecified primary analysis, we related sex-specific quartiles of HOMA-IR and glycemia categories to CMR measures. We used sex-specific ANCOVA to assess trends in adjusted means of CMR measures across glycemia categories and HOMA-IR quartiles in a 2-step fashion: Step 1 adjusted for age alone and step 2 adjusted jointly for age, systolic blood pressure, BMI, smoking status, and use of cardioactive drugs.
In secondary analyses, we related quartiles of 2-hour glucose and 2-hour insulin with CMR measures in the subgroup of participants who underwent oral glucose tolerance testing. Finally, we performed multivariable stepwise selection analysis relating HOMA-IR and glycemia categories to CMR measures to elucidate the significant covariates contributing to the associations.
Results are presented as trends in adjusted mean values for CMR measures with a test for linear trend. We individually tested for linear trend between the quartiles of HOMA-IR and glycemic categories with the CMR measures by entering the quartile or category (coded 0, 1, 2, and 3) as a continuous variable in the ANCOVA model. The test for linear trend comprised of the 1 degree of freedom t test for the quartile. A significant linear trend test implies the trajectory of the CMR measure increases or decreases with increasing HOMA-IR quartile or glycemic category. Conversely, a nonsignificant trend test implies there is no decreasing or increasing trajectory across quartiles/categories. All analyses were performed with SAS version 8.1 (SAS Institute, Cary, NC). A 2-sided probability value of 0.05 was used to ascertain statistical significance.
Results
Clinical and biochemical characteristics and summary statistics of CMR measures by sex are shown in Table 1 . Mean age for the entire group was 64Ϯ9 years. Men had a higher BMI and greater prevalence of hypertension compared with women. Nine percent of men and 6% of women had diabetes.
Oral glucose tolerance data were available in one third of participants (253 men, 290 women).
Relations of HOMA-IR to CMR Measures
For both men and women, all age-adjusted CMR measures increased significantly across quartiles of HOMA-IR (all PϽ0.005; Table 2 ). In multivariable analyses, we observed a significant increasing linear trend in mean LVM/LVEDV (PϽ0.005). We noted a significant decreasing trend in mean LVM/ht 2.7 (PϽ0.05) across quartiles of HOMA-IR in both men and women consistent with a prior report from Framingham. The significant decreasing trend in association with LVM/ht 2.7 is seen in the multivariable model that includes BMI in the model, whereas a significant increasing trend is noted in the age-adjusted model ( Table 2 ) and in models that included all of the covariates except BMI (data not shown). In men (but not in women), we also observed a modest yet statistically significant increasing linear trend in mean EF across HOMA-IR quartiles, after multivariable adjustment (Pϭ0.009; Table 2 ). However, the trends we observed for age-adjusted means of left atrial dimension (LAD), RWT, and cardiac output (CO) were not statistically significant on multivariable adjustment, in both men and women.
Relations of Glycemia Categories to CMR Measures
Summary data for the groups with prediabetes, diabetes, and high fasting plasma glucose/high fasting plasma insulin and normal groups are presented in Table 3 . In age-adjusted analy-ses, we observed that CMR measures were lowest in the normal group, intermediate in the impaired insulinemia/glycemia group, and highest in the prediabetes and diabetes groups. These trends were statistically significant (PϽ0.005) in age-adjusted analyses for all CMR measures in both sexes except for EF. Participants with prediabetes had similar elevations in CMR measures compared with those with diabetes. On multivariable adjustment, these associations were not statistically significant in women. However, in men, both LVM/LVEDV and RWT continued to demonstrate a modest but significant increasing trend even after multivariable adjustment. The associations of LAD, LVM/ht 2.7 , EF, and CO were not statistically significant after multivariable adjustment.
Relations of 2-Hour Insulin to CMR Measures
When relations of 2-hour insulin to CMR measures were evaluated in women, we found a pattern similar to that observed with the glycemia categories, whereas adjusted means of CMR measures increased across quartiles of 2-hour insulin, the relations were not statistically significant after multivariable adjustment (Supplementary Table 2 ). In men, covariate-adjusted mean LVM/LVEDV increased significantly across increasing quartiles of 2-hour insulin in multivariable adjusted analyses. Associations of LAD, LVM/ht 2.7 , RWT, EF, and CO with 2-hour insulin were not statistically significant in multivariable analyses in men.
Relations of 2-Hour Glucose to CMR Measures
In men, we observed an increasing trend of LVM/LVEDV, RWT, and CO across quartiles of 2-hour glucose, in age- 
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adjusted but not in multivariable adjusted models (Supplementary Table 3 ). LAD, LVM/ht 2.7 , and EF were not associated with 2-hour glucose in men. In women, we observed that only RWT was significantly associated with 2-hour glucose in multivariable adjusted models ( Supplementary Table 3 ).
Stepwise Selection Analyses
We performed stepwise selection including 1 covariate at a time in the multivariable models. We observed that in those multivariable analyses relating HOMA-IR and glycemia categories to CMR measures that were nonsignificant, glycemia measures lost statistical significance observed in the ageadjusted analyses on inclusion of BMI.
Discussion
Principal Findings
In this middle-aged to elderly community-based cohort, we demonstrate that higher levels of HOMA-IR are associated with increasing LVM/ht 2.7 and LVM/LVEDV in both sexes. On multivariable adjustment (especially BMI), the trend in LVM/ht 2.7 is reversed, suggesting that the association between insulin resistance and LVM/ht 2.7 is modified by covariates (mainly BMI). The direction and significance of association between HOMA-IR and LVM/LVEDV was unchanged by multivariable adjustment, suggesting a graded increase in concentricity with increasing insulin resistance. We also observed a graded increase in LVM/LVEDV and RWT across glycemia categories in men but not in women. Associations of 2-hour insulin and glucose with CMR measures in women were similar to those seen with glycemia categories; however, in men, increasing concentricity continued to be a significant correlate of 2-hour insulin. An intriguing finding of our investigation is the consistent association between glycemic abnormalities and ventricular concentricity (LVM/LVEDV), only in men. Adjustment for BMI caused a loss of statistical significance for this relation- ship only in the ANCOVA evaluating 2-hour glucose. This suggests that both rising HOMA-IR and movement into a worse glycemia category may influence ventricular remodeling, independent of other correlates of concentricity such as blood pressure and BMI. Our study thus extends the findings of prior investigations that reported increased prevalence of concentric remodeling in those with diabetes, insulin resistance, and glucose intolerance. 12
Comparison to Previous CMR Literature
Two prior investigations using a different segmented k-space gradient echo CMR imaging sequence evaluated participants from the Multi-ethnic Study of Atherosclerosis (MESA) and reported on the associations of glycemia indices to CMR measures of absolute LVM and LVEDV. Bertoni et al 27 observed that in multivariable-adjusted analyses, participants with diabetes and impaired fasting glucose did not have a significantly higher LVM but had significantly lower LVEDV. In a subsequent MESA report, Heckbert et al 28 reported that participants with diabetes had a higher LVM and lower LVEDV, whereas participants with impaired fasting glucose had a lower LVEDV compared with those with normal glucose tolerance. Although neither study reported LVM/LVEDV, their findings that are consistent with an association of increased concentricity with diabetes and glycemic abnormalities. In our study, we directly assessed LVM/LVEDV in a comprehensive set of analyses evaluating its relationship to insulin resistance, glycemia categories, and 2-hour insulin and glucose. When we evaluated the individual components of LVM/LVEDV, we observed a decreasing trend in LVEDV across quartiles of HOMA-IR (Supplementary Table 4 ) and categories of glycemia (Supplementary "Normal" group includes participants with both fasting plasma glucose Յ100 mg/dL and fasting plasma insulin Յ75th percentile of distribution; "High FPI/FPG" group includes those with either fasting plasma insulin Ͼ75th percentile of distribution or fasting plasma glucose Ͼ100 mg/dL (but not both); and "prediabetes" includes those without diabetes but with both fasting plasma glucose Ͼ100 mg/dL and fasting plasma insulin Ͼ75th percentile of distribution. *P value for linear trend.
evaluated 3D volumetric change are limited by greater variability.
Contrasts With Prior Echocardiography Literature
As noted previously, investigations relating glycemic abnormalities to transthoracic echocardiographic measures of cardiac structure and function reported conflicting results. In a previous Framingham Heart Study report, Rutter et el 10 noted increasing LVM with worsening glycemia status (but not with insulin resistance) that was more striking in women. The effect was largely attenuated by adjustment for BMI. In contrast, Devereux et al 29 
Mechanisms Underlying the Associations
Experimental evidence and observations in humans implicate hyperglycemia, hyperinsulinemia, and impaired responses to a glucose load in ventricular remodeling. Experimentally induced hyperinsulinemia in rats leads to increased body mass, relative myocardial mass and blood pressure, and lower cardiac output 31 and also causes characteristic changes in angiotensin receptor expression leading to modulation of ventricular remodeling responses to blood pressure. 32 Panagia et al 33 reported that db/db mice (an animal model of type 2 diabetes) had lower cardiac output and impaired postischemic recovery compared with control mice. Similarly, serial CMR measurements in db/db mice demonstrate a progressive increase in LVM and RWT followed by a later increase in LV end-diastolic dimension and decrease in contractile function. 34 Potential molecular mechanisms underlying the effects of insulin and glucose on the myocardium in humans are extensively reviewed elsewhere. [35] [36] [37] 
Limitations
Our study has several limitations. We used a cross-sectional design in a middle-aged to elderly Caucasian population that limits our ability to draw causal inferences or generalize to other age or ethnic groups. We had a single measurement of insulin and glucose; longitudinal measures may be more reflective of the effects on the heart. Finally, only a third of our cohort had oral glucose tolerance test results available, limiting our ability to fully evaluate the relations of 2-hour insulin and glucose to CMR measures.
Conclusions
In a free-living adult population without clinical coronary disease, we observed a fairly consistent association of abnormalities in insulin and glucose levels and insulin resistance with LVM/LVEDV, and we found that LVM/LVEDV was consistently associated with hyperglycemia and insulin resistance in multivariable analyses. However, the associations of diabetes, insulin resistance, and subclinical glycemia abnormalities with LVM/ht 2.7 and other structural and functional abnormalities were primarily mediated by elevated BMI. These data suggest an important role for hyperglycemia and insulin resistance in concentric LV remodeling.
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